ENG rs121918400: Understanding Hereditary Hemorrhagic Telangiectasia

What each genotype means

What is rs121918400?

The variant rs121918400 is a single nucleotide polymorphism (SNP) located on chromosome 9. In the context of the ENG gene, this specific change is categorized as a pathogenic variant. Genetic variants are essentially small differences in the DNA sequence that can alter how a gene functions. While many variants are benign and have no impact on health, others, like rs121918400, are identified because they disrupt the normal production or function of proteins essential for bodily processes. Because this variant is rare, it is not typically found in the general population and is usually identified through targeted clinical genetic testing when a patient presents with specific symptoms or a family history of vascular conditions.

The Role of the ENG Gene

The ENG gene provides instructions for making a protein called endoglin. This protein is primarily found on the surface of endothelial cells, which are the cells that line the interior of blood vessels. Endoglin plays a critical role in the transforming growth factor-beta (TGF-beta) signaling pathway, which is essential for maintaining the structural integrity of blood vessels and regulating the formation of new blood vessels, a process known as angiogenesis. When the ENG gene is mutated, the resulting endoglin protein may be absent or non-functional. This deficiency leads to a condition known as haploinsufficiency, where the body cannot produce enough functional protein to maintain healthy vascular walls, ultimately resulting in the fragile blood vessels characteristic of hereditary hemorrhagic telangiectasia.

Research and Clinical Associations

Research has firmly established a link between mutations in the ENG gene and hereditary hemorrhagic telangiectasia type 1 (HHT1). HHT1 is an autosomal dominant disorder, meaning that a single copy of the altered gene is sufficient to cause the condition. Individuals with HHT1 often experience recurrent nosebleeds, telangiectasias (small, dilated blood vessels near the skin surface), and potentially more severe arteriovenous malformations in organs like the lungs, liver, or brain. The evidence for the pathogenicity of variants in the ENG gene is considered high, and the gene is included in clinical panels for vascular disorders. It is important to note that while the presence of a pathogenic variant confirms a genetic predisposition, the severity and specific symptoms of HHT can vary significantly even among family members with the same mutation.

Population Frequency

The rs121918400 variant is classified as very rare in the general population. Because it is a pathogenic variant associated with a specific clinical condition, it is not expected to be found at high frequencies in large-scale genomic databases of healthy individuals. Its presence is typically documented in clinical settings among individuals who have been diagnosed with or are being screened for HHT1.

Managing Genetic Information

If you or a family member have been identified as a carrier of a pathogenic ENG variant, it is essential to consult with a medical geneticist or a specialized clinician. This information is not a diagnosis in itself but a tool that helps healthcare providers understand your health risks and develop appropriate monitoring plans. Because HHT1 can involve internal vascular malformations, doctors may recommend periodic screening, such as imaging studies, to detect and manage potential complications early. You should never use genetic information to make independent medical decisions or change treatments without professional guidance. Always discuss your genetic results with a qualified healthcare provider who can interpret the findings in the context of your personal and family medical history.

Frequently asked questions

Sources & further reading

Related variants in ENG